Ads
related to: zoetis petcare rewards cytopoint program
Search results
Results From The WOW.Com Content Network
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [ 5 ] [ 4 ] [ 6 ] The company was a subsidiary of Pfizer , [ 7 ] the world's largest drug maker , but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
The United States Department of Agriculture (USDA) approved lokivetmab (manufactured by Zoetis and sold under the trade name Cytopoint) in December 2016, [3] and it was approved by the European Medicines Agency in 2017. [4] Lokivetmab was the first monoclonal antibody to be approved for use in animals in the European Union. [4]
Zoetis (NYSE: ZTS) Q2 2024 Earnings Call Aug 06, ... Simparica Trio, and Cytopoint. With our global footprint and world-class manufacturing facilities, we ensure consistent quality and on-time ...
Zoetis (NYSE: ZTS) Q3 2024 Earnings Call Nov 04, ... and Librela has already become the fourth largest product in U.S. pet care. This highlights the demand and long-term growth potential ...
Mars Petcare is primarily pet food manufacturing and brands as well as pet healthcare services, technologies, and brands. [5] Mars Veterinary Health.
Zoetis said in May that despite lower visits to vet clinics for wellness and diagnostic products, the company's growth was being driven by its medical treatments for chronic conditions in pets.